Wall Street Bullish These Chip Stocks: Intel vs Marvell Showdown
Wall Street is split on two big AI chips players: Intel and Marvell. One stock is riding optimism about data-center d...
When Is Stock Index Value Updated
Stock index values update on scheduled times or upon data arrivals, varying by index and exchange. This piece covers the timing and implications.
22,965 articles
Rayonier (RYN) 2026 Earnings Outlook: Revenue, Growth, Risks
Investors are watching rayonier (ryn) 2026 earnings as timber demand and housing trends shape the outlook. This guide...
SpaceX Fell Below Debut: What a $10K Invested Looks Like
SpaceX dazzled investors at IPO, but the price soon drifted below debut. This article shows how a $10,000 investment ...
DocuSign (DOCU) 2027 Earnings Outlook: Revenue Path
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
Advanced Micro Devices: Strong Contender in Tech Arena
AMD is positioning itself as a robust player across consumer, data center, and AI markets. This article breaks down w...
Intel Arrow Lake Refresh: Budget CPU That Competes with AMD
Intel Arrow Lake Refresh introduces budget-friendly CPUs with stronger cores, bigger caches, and aggressive pricing. ...
Covered-Call MSTY Caps Your Gains, Risks Rise for Investors
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...
NuScale Impossible Ignore Right: What Investors Should Do
NuScale has become a polarizing name in energy investing, swinging between hype and risk. This guide breaks down the ...
Stock Market Today, March: Rivian Uber Robotaxi Bet
A major EV maker partners with Uber on a robotaxi plan, sending ripples through the market. This guide breaks down wh...
Dividend Stocks Hold Next: 3 Picks for a 10-Year Path
In a market obsessed with disruptive tech, reliable dividend stocks hold next decade. Discover three time-tested pick...
What Does Opendoor Director's Sale Mean for Investors
When a Opendoor director sells a sizable stake, investors wonder if it hints at trouble or simply liquidity needs. Th...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status